Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study - Wechsler, M E; Menzies-Gow, A; Brightling, C E; SOURCE study group (Lancet Respir Med, 2022)